Literature DB >> 1455096

Molecular adaptation of hemoglobin function in mammals.

C Poyart1, H Wajcman, J Kister.   

Abstract

Vertebrate hemoglobins are tetramers made of two pairs of alpha and beta subunits each containing a hydrophobic pocket where a heme molecule binds tightly and allows for the reversible binding of oxygen. Both tertiary and quaternary structures are ideally suited for the loading and unloading of oxygen necessary for the metabolic requirements of the organisms. Starting from a single ancestor hemoglobin subunit, evolutionary processes have led to heterologous tetramers exhibiting a moderate oxygen affinity due to heme-heme interaction (allosteric mechanism) which may be further modulated through electrostatic interactions with chloride and/or organophosphate anions present in the red cells. These effectors, which bind preferentially to the deoxy-Hb tetramers at a distance from the heme groups, play a major role in the adaptation of the respiratory properties of hemoglobin to either allometric-dependent oxygen needs or to various hypoxic environments such as altitude, burrowing, or foetal life. In most cases the existence or the strength of the effector-Hb complexes, hence the changes in the allosteric equilibrium, may be ascribed to one or a few mutations of residues at the effector binding sites. Typical examples of these mechanisms are described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1455096     DOI: 10.1016/0034-5687(92)90130-o

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  17 in total

1.  Darwinian adaptation of proteorhodopsin to different light intensities in the marine environment.

Authors:  Joseph P Bielawski; Katherine A Dunn; Gazalah Sabehi; Oded Béjà
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

2.  Gene conversion and functional divergence in the beta-globin gene family.

Authors:  Gabriela Aguileta; Joseph P Bielawski; Ziheng Yang
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

3.  Brain alpha- and beta-globin expression after intracerebral hemorrhage.

Authors:  Yangdong He; Ya Hua; Jin-Yul Lee; Wenquan Liu; Richard F Keep; Michael M Wang; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-03       Impact factor: 6.829

4.  A maximum likelihood method for detecting functional divergence at individual codon sites, with application to gene family evolution.

Authors:  Joseph P Bielawski; Ziheng Yang
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

Review 5.  Mechanisms of hemoglobin adaptation to high altitude hypoxia.

Authors:  Jay F Storz; Hideaki Moriyama
Journal:  High Alt Med Biol       Date:  2008       Impact factor: 1.981

6.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Evidence for contrasting modes of selection at interacting globin genes in the European rabbit (Oryctolagus cuniculus).

Authors:  R Campos; J F Storz; N Ferrand
Journal:  Heredity (Edinb)       Date:  2008-04-30       Impact factor: 3.821

8.  Complex signatures of selection and gene conversion in the duplicated globin genes of house mice.

Authors:  Jay F Storz; Monica Baze; Jessica L Waite; Federico G Hoffmann; Juan C Opazo; Jack P Hayes
Journal:  Genetics       Date:  2007-07-29       Impact factor: 4.562

9.  Effects of cerebral ischemia on neuronal hemoglobin.

Authors:  Yangdong He; Ya Hua; Wenquan Liu; Haitao Hu; Richard F Keep; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2008-12-10       Impact factor: 6.200

10.  Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Jian Cai; Angela D Kain; David W Powell; Markus H Kuehn; William M Pierce
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.